PRESTIGE
Investo's verdict, shared with you
No fair value published
The derivation ran and was refused by our own plausibility checks. We publish no number rather than a plausible-looking one.
Why · 3 checks
Our valuation methods disagree
The earnings-based and book-based readings of this company differ by more than 2.5×. That spread is real information, but averaging it would manufacture a number no method actually produced.
Implied earnings multiple is far from the peer group
At the computed value this company would trade at a P/E a long way from its sector median. Either the earnings input or the peer anchor is unreliable.
A per-share input was repaired or refused
One of the per-share figures behind this valuation did not agree with the audited totals it should reconcile to, so it was recomputed from those totals or rejected outright.
What we would need
- Earnings and book value drawn from the same set of accounts, so the two legs can be reconciled.
- A verified earnings figure, or a peer group with enough clean constituents to anchor against.
- A per-share figure in the source data that reconciles to the reported totals.
Show what the engine computed
Method spread · 83.00× between the highest and lowest valuation leg.
Methods disagree · The valuation legs disagree by 83x (Blended P/E band ₦0.02 vs Blended P/B band ₦1.66 vs Justified P/B ₦0.64). No point estimate is defensible until the inputs are reconciled.
Implied P/E off peers · Implied P/E at base 407.16x is 54.87x the sector median 7.42x.
Figure corrected · independently sourced EPS ₦0.05 is 23.18x our filing-derived ₦0.00 — one of the two earnings bases is wrong; the P/E leg is unreliable until resolved
Input quality · independently sourced EPS ₦0.05 is 23.18x our filing-derived ₦0.00 — one of the two earnings bases is wrong; the P/E leg is unreliable until resolved
Prestige Assurance trades at ₦1.44 against a P/B-anchored base fair value of ₦0.88, implying the stock is materially rich on the only defensible valuation leg available — book value — while earnings-based valuation is entirely unusable due to a 23x EPS discrepancy between the filing-derived figure (₦0.00) and our independent data source figure (₦0.05). The committee score is net negative (-1), with quality and momentum both flagged as negative, leaving no quality offset to justify the premium to book. Q2 2026 results show promising insurance service result growth but a 16% gross premium written decline, making the earnings recovery thesis uncertain.
Verdict published 2026-08-18 · fundamentals through 30 September 2026 · reviewed as the data changes
Verdict moderated to Watch — Avoid was refused
The valuation legs disagree by 83x, so there is no defensible valuation behind an extreme call.
Source: NGX live market data · Investo intelligence. Educational only — not financial advice.